EP1256817A1 - Tomographe a emission de positrons - Google Patents

Tomographe a emission de positrons Download PDF

Info

Publication number
EP1256817A1
EP1256817A1 EP01951111A EP01951111A EP1256817A1 EP 1256817 A1 EP1256817 A1 EP 1256817A1 EP 01951111 A EP01951111 A EP 01951111A EP 01951111 A EP01951111 A EP 01951111A EP 1256817 A1 EP1256817 A1 EP 1256817A1
Authority
EP
European Patent Office
Prior art keywords
region
interest
data
measurement
radiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP01951111A
Other languages
German (de)
English (en)
Other versions
EP1256817A4 (fr
EP1256817B1 (fr
Inventor
Hiroyuki c/o Hamamatsu Photonics K.K. OHBA
Hideo c/o Hamamatsu Photonics K.K. TSUKADA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hamamatsu Photonics KK
Original Assignee
Hamamatsu Photonics KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hamamatsu Photonics KK filed Critical Hamamatsu Photonics KK
Publication of EP1256817A1 publication Critical patent/EP1256817A1/fr
Publication of EP1256817A4 publication Critical patent/EP1256817A4/fr
Application granted granted Critical
Publication of EP1256817B1 publication Critical patent/EP1256817B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01T—MEASUREMENT OF NUCLEAR OR X-RADIATION
    • G01T1/00—Measuring X-radiation, gamma radiation, corpuscular radiation, or cosmic radiation
    • G01T1/29—Measurement performed on radiation beams, e.g. position or section of the beam; Measurement of spatial distribution of radiation
    • G01T1/2914—Measurement of spatial distribution of radiation
    • G01T1/2985—In depth localisation, e.g. using positron emitters; Tomographic imaging (longitudinal and transverse section imaging; apparatus for radiation diagnosis sequentially in different planes, steroscopic radiation diagnosis)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/02—Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computerised tomographs
    • A61B6/037—Emission tomography

Definitions

  • the present invention relates to a positron emission tomography apparatus that can be suitably used for example in the evaluation of a drug being tested.
  • a positron-emitting labeled substance is administered into a subject, and also coincidence counting is carried out of radiation generated in a measurement-subjected part of the subject accompanying electron-positron pair annihilation, and the spatial distribution of the radiation concentration in the measurement-subjected part is measured and made into an image, and hence for example changes in the amount accumulated of the labeled substance in a specific region of interest of the measurement-subjected part are studied; PET apparatuses are being applied to the evaluation of drugs for Alzheimer-type or vascular-type dementia and so on.
  • Fig. 10 is a block diagram showing the constitution of a conventional PET apparatus.
  • the PET apparatus 100 has a detection unit 101, a data collection unit 102, an image reconstruction unit 103, and an intravenous injection unit 104.
  • the data collection unit 102 has a frame-dependent histogram count memory 105.
  • a labeled substance T is intravenously injected into a subject S (for example a monkey) using the intravenous injection unit 104.
  • the measurement-subjected part H (for example the head) of the subject S is inserted into a measurement space within the detection unit 101, and then coincidence counting of radiation emitted by the labeled substance T that has reached the head of the subject S is carried out by the detection unit 101, and the coincidence count data is transmitted to the data collection unit 102.
  • the transmitted coincidence count data is accumulated in the frame-dependent histogram count memory 105, and is summed in accordance with the image frame.
  • the summed data is then sent to the image reconstruction unit 103, and based on this the radiation concentration distribution in the measurement-subjected part H of the subject S is made into an image.
  • the drug being tested Y is administered to the subject S. Then, by carrying out numerical analysis of the radiation concentrations obtained as described above based on physiological constants characteristic of the subject S and so on, the change and so on in the accumulated amount of the labeled substance T in a region of interest of the measurement-subjected part H between before and after the administration of the drug being tested Y is obtained.
  • the S/N ratio drops during the latter half of the measurements due to the half life of the labeled substance, and hence to compensate for this the amount administered of the labeled substance must be set rather high. Consequently, the radiation exposure dose to the subject becomes high, and moreover it is necessary to make the radiation concentration measurement range of the PET apparatus broad so that radiation concentrations from the high radiation concentrations at the start of the measurements to the low radiation concentrations during the latter half of the measurements can be measured.
  • PET apparatus positron emission tomography apparatus
  • the positron emission tomography apparatus (PET apparatus) which is a PET apparatus that administers a positron-emitting labeled substance into a subject, and also carries out coincidence counting of radiation generated in a measurement-subjected part of the subject accompanying electron-positron pair annihilation, and measures the spatial distribution of the radiation concentration in the measurement-subjected part, is characterized by having region-of-interest data extraction means for extracting radiation data for a specified region of interest from out of the radiation data that has been obtained by coincidence counting from the measurement-subjected part, administration condition calculation means for calculating an optimum administration condition for the labeled substance into the subject based on the extracted radiation data for the region of interest, and administration control means for carrying out feedback control of an administration condition for the labeled substance into the subject based on the optimum administration condition.
  • region-of-interest data extraction means for extracting radiation data for a specified region of interest from out of the radiation data that has been obtained by coincidence counting from the measurement-subjected part
  • radiation data for a region of interest of the measurement-subjected part is extracted for example for each frame, and then an optimum administration condition (e.g. amount administered per unit time) for the labeled substance such that the radiation concentration for the region of interest becomes steady regardless of the physiological state (blood flow rate etc.) of the subject is calculated based on the radiation data, and feedback control is carried out of the amount administered or the like of the labeled substance to the subject in accordance with the optimum administration condition.
  • an optimum administration condition e.g. amount administered per unit time
  • PET apparatus positron emission tomography apparatus
  • Fig. 1 is a block diagram of the constitution of the PET apparatus 1 according to the first embodiment.
  • the PET apparatus 1 comprises a detection unit 10, a data collection unit 20, an image information control unit 30, an intravenous injection unit 40, a calculation processing unit 50, an administration rate control unit 60, and a display unit 70.
  • the detection unit 10 has contained therein a measurement space into which a measurement-subjected part (for example the head) H of a subject (for example a monkey) S can be placed, and a large number of detectors are arranged in a ring around the central axis. For each of these detectors, the ray-receiving surface faces into the measurement space, and hence the detector detects radiation emitted from the measurement space side.
  • a measurement-subjected part for example the head
  • a subject for example a monkey
  • Each of the detectors of the detection unit 10 is connected to the data collection unit 20 by a signal line, and detection signals that depend on the energy of the detected radiation are transmitted from the detectors to the data collection unit 20.
  • the data collection unit 20 has an imaged-frame-dependent histogram memory 21 and an imaged-frame-independent histogram memory 22.
  • the data collection unit 20 recognizes when a pair of detectors out of the large number of detectors constituting the detection unit 10 have simultaneously detected radiation (energy 511keV) generated accompanying electron-positron pair annihilation based on the detection signals transmitted from the detection unit 10, and stores the coincidence count data based on the detection signals in the imaged-frame-dependent histogram memory 21 and the imaged-frame-independent histogram memory 22.
  • the imaged-frame-dependent histogram memory 21 is connected to the image information control unit 30 by a signal line. Moreover, the imaged-frame-independent histogram memory 22 is connected to the calculation processing unit 50 by a signal line. The data accumulated and summed in the imaged-frame-dependent histogram memory 21 is transmitted to the image information control unit 30 in accordance with the imaged frames (time periods that act to delimit the data collection), which are preset.
  • the image information control unit 30 has an image information memory 31, and information such as a mask image created in advance before commencing measurement is stored in this image information memory 31.
  • the image information control unit 30 is connected to the calculation processing unit 50 by a signal line, and image information and so on stored in the image information memory 31 is transmitted to the calculation processing unit 50 in accordance with the imaged frames and so on.
  • the intravenous injection unit 40 has an injection needle for carrying out intravenous injection into the subject S, and a pump or the like for injecting the labeled substance T into the subject S. During the measurement period, the injection needle is kept in a state inserted into the subject S, and the labeled substance T is continuously administered using the pump. Moreover, the pump has a structure such that it is possible to change the rate of intravenous injection of the labeled substance T upon receiving control from the administration rate control unit 60, which is the administration control means.
  • the calculation processing unit 50 extracts radiation data for a specified region of interest K in the measurement-subj ected part H based on the coincidence count data transmitted from the imaged-frame-independent histogram memory 22 and the image information transmitted from the image information control unit 30 and so on, and calculates the radiation concentration for the region of interest K and the optimum administration rate (intravenously injected amount per unit time).
  • the calculation processing unit 50 is connected to the administration rate control unit 60 and the display unit 70 by signal lines; the calculated radiation concentration for the region of interest K is transmitted to the display unit 70, and the calculated optimum administration rate is transmitted to the administration rate control unit 60.
  • the administration rate control unit 60 is connected to the intravenous injection unit 40 by a signal line, and controls the rate of administration by the intravenous injection unit 40 based on the transmitted optimum administration rate information.
  • the display unit 70 is a liquid crystal monitor or the like, and displays the transmitted radiation concentration for the region of interest K as a graph or the like.
  • an MRI anatomical image or the like of the measurement-subjected part H of the subject S that has been measured in advance is inputted into the image information memory 31 of the image information control unit 30 (step 1-1; hereinafter steps are abbreviated to 'S1-1' and so on) .
  • the region of interest K is set on this image (S1-2).
  • the region of interest K is a part where the amount accumulated or the like of the labeled substance T changes through the administration of the drug being tested Y, and is selected as appropriate in accordance with the type of the drug being tested Y, the objective and so on.
  • a mask image that leaves behind only the data for the region of interest K is created based on the set image (S1-3).
  • 1 is set within the region of interest K
  • 0 is set in the region other than the region of interest K.
  • the measurement-subjected part H of the subject S is inserted into the measurement space of the detection unit 10, and administration of the labeled substance T (for example a compound containing positron-emitting 15 O or the like) into the subject S is commenced.
  • Coincidence counting of the radiation generated from the measurement-subjected part H due to electron-positron pair annihilation is then carried out, and the coincidence count data is collected in the imaged-frame-dependent histogram memory 21 and the imaged-frame-independent histogram memory 2.2 (S1-11).
  • the coincidence count data is collected repeatedly until one frame has been completed, with the coincidence count data being accumulated in the imaged-frame-dependent histogram memory 21 and the imaged-frame-independent histogram memory 22.
  • the summed coincidence count data is transmitted to the calculation processing unit 50, and reconstruction of the PET image (radiation data image) of the measurement-subjected part H is carried out based on the coincidence count data (S1-12).
  • the pre-aligned mask image is transmitted from the image information control unit 30 to the calculation processing unit 50.
  • the reconstructed PET image and the mask image are then composited in the calculation processing unit 50 (S1-13).
  • the PET image for the region of interest K i.e. an image that shows the radiation concentration distribution within the region of interest
  • PET data radiotherapy concentration data
  • This PET data for the region of interest K is transmitted to the display unit 70, and is displayed as a graph or the like.
  • the optimum administration rate such that the radiation concentration for the region of interest K will be steady is calculated based on the PET data for the region of interest K (S1-15).
  • the deviation between the reference input function graph that has been created in advance and the graph from the calculated PET data is calculated (S1-24).
  • the optimum administration rate of the labeled substance T for correcting this deviation is then calculated (S1-25). Note that the graph from the PET data obtained for this frame may be substituted for the preset reference input function graph, and used as the reference input function graph for the next frame.
  • the administration rate control unit 60 carries out feedback control such that the administration rate (administration condition) of the labeled substance T in the intravenous injection unit 40 becomes the optimum administration rate (S1-16).
  • the measurement progresses to the next frame.
  • the intravenous injection unit 40 administers the labeled substance T to the subject S at the calculated optimum administration rate.
  • the above processing is repeated, progressing from frame to frame. Because feedback control of the administration rate is carried out for each frame, as the frames are progressed through, the radiation concentration generated from the region of interest K becomes steady.
  • the drug being tested Y is administered to the subject S after the radiation concentration generated from the region of interest K has reached a steady state.
  • the drug being tested Y is then evaluated by observing the change in the radiation concentration generated from the region of interest K (i.e. the change in the amount accumulated of the labeled substance T) .
  • Fig. 5 is a graph showing the changes over time in the radiation concentration for the region of interest in the case of the PET apparatus according to the present embodiment; such a graph can be visually checked in real time on the display unit 70.
  • the changes over time in the radiation concentration generated from the region of interest K can broadly be divided into 3 periods.
  • the first period P1 is a stage when the radiation concentration for the region of interest K is still not stable, depending on the blood flow rate and so on.
  • the second period P2 is a stage when, due to feedback control of the administration rate of the labeled substance T having been carried out, the radiation concentration for the region of interest K has reached a steady state.
  • the third period P3 is a stage when changes have arisen in the radiation concentration for the region of interest K, which had been in a steady state, due to administration of the drug being tested Y. In the present embodiment, the effect of the drug being tested Y is evaluated by studying the changes in the radiation concentration for the region of interest K during the period P3.
  • the optimum administration rate of the labeled substance such that the radiation concentration for the region of interest K will be steady regardless of the physiological state (blood flow rate etc.) of the subject S is calculated as an optimum administration condition, this being based on the radiation concentration data for the region of interest K obtained from the coincidence count data.
  • Feedback control of the administration rate of the labeled substance T to the subject S is then carried out based on the calculated optimum administration rate.
  • the extracted radiation concentration data is displayed in real time on the display unit 70 as a graph or the like. It thus becomes possible to visually check changes and so on in the radiation concentration for the region of interest K easily in real time, and hence the measurement results and so on can be judged rapidly.
  • the PET apparatus 1 by extracting the radiation data for the region of interest as an image, the accuracy of the extraction can be raised, and in addition the extraction can be carried out as radiation concentrations, not as coincidence count data.
  • a reference input function graph is created in advance, and the administration rate of the labeled substance T such as to correct the deviation from the reference input function graph is calculated.
  • PET apparatus positron emission tomography apparatus
  • the constitution of the PET apparatus 2 according to the second embodiment is very similar to that of the first embodiment, and hence here a description will be given of the operation of the PET apparatus 2 with reference to the flowchart shown in Fig. 6, focusing in particular on the region-of-interest data extraction processing, the administration rate calculation processing and the administration rate control processing.
  • an MRI anatomical image or the like of the measurement-subjected part H of the subject S that has been measured in advance is inputted into the image information memory 31 of the image information control unit 30 (S2-1), and then the region of interest K is set on this image (S2-2).
  • a mask image that leaves behind only the data for the region of interest K is created based on the set image (S2-3), and then alignment of the mask image and the PET image is carried out (S2-4). After this, in the present embodiment, forward projection of the mask image onto projection data is carried out, thus creating a projected mask (S2-5).
  • measurement is commenced.
  • the measurement-subjected part H of the subject S is inserted into the measurement space of the detection unit 10, and administration of the labeled substance T into the subject S is commenced.
  • Coincidence counting of the radiation generated from the measurement-subjected part is then carried out, and the coincidence count data is collected in the imaged-frame-dependent histogram memory 21 and the imaged-frame-independent histogram memory 22 (S2-11).
  • the coincidence count data is collected repeatedly until one frame has been completed, with the coincidence count data being accumulated in the imaged-frame-dependent histogram memory 21 and the imaged-frame-independent histogram memory 22.
  • the summed coincidence count data is transmitted to the calculation processing unit 50, and forward projection of this data onto the projection data is carried out (S2-12).
  • the pre-aligned projected mask is transmitted onto the projection data in the calculation processing unit 50 from the image information control unit 30.
  • the projected PET data (projected radiation data) and the projected mask are then composited in the calculation processing unit 50 (S2-13). Through this composition, the projected PET data for the region of interest K is extracted, for example as shown in Fig. 7.
  • PET data for the region of interest K is obtained based on the extracted projected PET data for the region of interest K (S2-14).
  • This PET data for the region of interest K is transmitted to the display unit 70, and is displayed as a graph or the like.
  • the optimum administration rate such that the radiation concentration for the region of interest K will be steady is calculated based on the PET data for the region of interest K (S2-15).
  • the administration rate control unit 60 carries out feedback control such that the administration rate of the labeled substance T in the intravenous injection unit 40 becomes the optimum administration rate (S2-16).
  • the measurement progresses to the next frame.
  • the intravenous injection unit 40 administers the labeled substance T into the subject S at the calculated optimum administration rate.
  • the PET apparatus 2 of the present embodiment because compositing is carried out of the projected radiation data for the region of interest K and the projected mask on the projection data, it becomes possible to improve the temporal resolution.
  • PET apparatus positron emission tomography apparatus
  • the constitution of the PET apparatus 3 according to the third embodiment is very similar to that of the first embodiment, and hence here a description will be given of the operation of the PET apparatus 3 with reference to the flowchart shown in Fig. 8, focusing in particular on the region-of-interest data extraction processing, the administration rate calculation processing and the administration rate control processing.
  • PET measurement is carried out in advance on the measurement-subjected part H of the subject S (S3-1).
  • a PET image is then reconstructed based on the PET data obtained through this preliminary PET measurement (S3-2).
  • anMRI anatomical image or the like of the measurement-subjected part H of the subject S that has been measured in advance is inputted into the image information memory 31 of the image information control unit 30, and the region of interest K is set on this image (S3-3).
  • a mask image that leaves behind only the data for the region of interest K is created based on the set image (S3-4), and then the mask image and the preliminary PET image are composited (S3-5).
  • the contribution rate to each detector pair from the region of interest K is calculated (S3-6).
  • This contribution rate is the proportion contributed by the radiation generated from the region of interest K out of the coincidence count value detected by the detector pair in question; for example, in the case shown in Fig. 9, a value between 0 and 1 is set for each detector pair based for example on the distance for which the line segment joining the pair of detectors cuts through the region of interest K or on the radiation concentration distribution obtained from the preliminary PET image.
  • a contribution rate table in which are collated the contribution rates for the respective detector pairs is then created (S3-7).
  • measurement is commenced.
  • the measurement-subjectedpart H of the subject S is inserted into the measurement space of the detection unit 10, and administration of the labeled substance T into the subject S is commenced.
  • Coincidence counting of the radiation generated from the measurement-subjected part is then carried out (S3-11).
  • the coincidence count data obtained is transmitted to the calculation processing unit 50 not frame by frame but rather in time series fashion.
  • the detector pairs that detected the coincidence count data are identified (S3-12).
  • the contribution rate table for the detector pairs which has been created in advance is transmitted to the calculation processing unit 50, and based on this the coincidence count data is subjected to weighting processing (S3-13). For example, in the case that the detection was by a detector pair for which the contribution rate is 0.7 (70%), a coincidence count of 1 is reduced to 0.7. Note that, at this time, a contribution rate table including the coincidence count data obtained may be newly created, with this being used when the next coincidence count data is subjected to the weighting processing.
  • PET data for the region of interest K is extracted (S3-14) based on the coincidence count data that has been weighted as described above.
  • This PET data for the region of interest K is transmitted to the display unit 70, and is displayed as a graph or the like.
  • the optimum administration rate such that the radiation concentration for the region of interest K will be steady is calculated based on the PET data for the region of interest K (S3-15).
  • the administration rate control unit 60 carries out feedback control such that the administration rate of the labeled substance T in the intravenous injection unit 40 becomes the optimum administration rate (S2-16).
  • the PET imaging progresses to the next frame once one frame has been completed.
  • the calculation and control of the optimum administration rate is carried out as appropriate independently of the frame, and hence the intravenous injection unit 40 administers the labeled substance T to the subject S at the optimum administration rate for the time in question.
  • the PET apparatus 3 of the present embodiment because time-series-type data based on each of the detector pairs is used, it becomes possible to extract radiation data for the region of interest K with an extremely high temporal resolution.
  • the positron emission tomography apparatus (PET apparatus) is not limited to the above embodiments, with it being possible to adopt various modifications in accordance with other conditions and so on.
  • the functions of the region-of-interest data extraction means for carrying out processing to extract the radiation data for the region of interest K, and the functions of the administration condition calculation means for carrying out processing to calculate the optimum administration condition are realized using a single calculation processing unit 50.
  • a constitution is also possible in which these pieces of processing are carried out by processing units provided separately via signal lines, i.e. by a region-of-interest data extraction processing unit and an administration condition calculation processing unit respectively.
  • the positron emission tomography apparatus (PET apparatus) according to the present invention can be used as a positron emission tomography apparatus that enables measurements to be carried out easily and precisely, and also enables measurement results to be grasped rapidly and easily.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Nuclear Medicine (AREA)
  • Image Processing (AREA)
  • Image Analysis (AREA)
EP01951111A 2000-02-07 2001-01-29 Tomographe a emission de positrons Expired - Lifetime EP1256817B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000029238A JP4408162B2 (ja) 2000-02-07 2000-02-07 ポジトロンエミッショントモグラフィ装置
JP2000029238 2000-02-07
PCT/JP2001/000579 WO2001059477A1 (fr) 2000-02-07 2001-01-29 Tomographe a emission de positrons

Publications (3)

Publication Number Publication Date
EP1256817A1 true EP1256817A1 (fr) 2002-11-13
EP1256817A4 EP1256817A4 (fr) 2003-05-21
EP1256817B1 EP1256817B1 (fr) 2005-12-14

Family

ID=18554527

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01951111A Expired - Lifetime EP1256817B1 (fr) 2000-02-07 2001-01-29 Tomographe a emission de positrons

Country Status (6)

Country Link
US (1) US7191109B2 (fr)
EP (1) EP1256817B1 (fr)
JP (1) JP4408162B2 (fr)
AU (1) AU2001228845A1 (fr)
DE (1) DE60115848T2 (fr)
WO (1) WO2001059477A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007054843A1 (fr) * 2005-11-10 2007-05-18 Koninklijke Philips Electronics, N.V. Imagerie par tomographie à émission de positrons avec masque de mode de liste anatomique
GB2450073A (en) * 2006-08-25 2008-12-17 Siemens Molecular Imaging Ltd Regional reconstructions of spatially distributed functions
CN103279964A (zh) * 2013-04-23 2013-09-04 浙江大学 一种基于prca的pet图像动态重建方法及系统
DE102014219196A1 (de) * 2014-09-23 2016-01-14 Siemens Aktiengesellschaft Verfahren und Vorrichtung zur Gewinnung zweier Bilder mittels zweier unterschiedlicher medizinischer Bildgebungsverfahren

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10214254A1 (de) * 2002-03-30 2003-10-16 Philips Intellectual Property Organspezifische Rückprojektion
EP1685427A2 (fr) * 2003-11-11 2006-08-02 Philips Intellectual Property & Standards GmbH Dispositif et procede pour determiner la concentration d'un traceur dans le sang
JP2005197792A (ja) * 2003-12-26 2005-07-21 Canon Inc 画像処理方法、画像処理装置、プログラム、記憶媒体及び画像処理システム
DE102005048853A1 (de) * 2005-10-12 2007-04-26 Siemens Ag Bildgebende medizinische Modalität
DE102005053994A1 (de) * 2005-11-10 2007-05-24 Siemens Ag Diagnosevorrichtung für kombinierte und/oder kombinierbare radiographische und nuklearmedizinische Untersuchungen sowie entsprechendes Diagnoseverfahren
JP4656233B2 (ja) * 2006-03-10 2011-03-23 株式会社島津製作所 核医学診断装置およびそれに用いられる診断システム
DE102006042572A1 (de) * 2006-09-11 2008-03-27 Siemens Ag Bildgebende medizinische Einheit
DE102008019645A1 (de) 2008-04-18 2009-10-22 Siemens Aktiengesellschaft Positronenemissionstomographie-Gerät
DE102010020605A1 (de) 2010-05-14 2011-11-17 Siemens Aktiengesellschaft Medizinische Untersuchungseinrichtung zur CT-Bildgebung und zur nuklearmedizinischen Bildgebung
JP6433681B2 (ja) * 2014-05-15 2018-12-05 浜松ホトニクス株式会社 薬物評価システム、薬物評価システムの作動方法、薬物評価プログラム及び記録媒体
US10733770B2 (en) * 2017-04-21 2020-08-04 General Electric Company System and method for performing fault-tolerant reconstruction of an image
CN109350099A (zh) * 2018-09-13 2019-02-19 中山市明峰医疗器械有限公司 一种应用于临床pet系统的随机事件去除处理方法
CN113925523B (zh) * 2020-06-29 2024-03-26 通用电气精准医疗有限责任公司 医疗成像系统的状态检测方法和装置以及ct成像系统检测

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150292A (en) * 1977-02-18 1979-04-17 Ter Pogossian Michel M Imaging device for computerized emission tomography
US4409966A (en) * 1981-05-29 1983-10-18 Lambrecht Richard M Method and apparatus for injecting a substance into the bloodstream of a subject
US5027817A (en) * 1989-06-22 1991-07-02 New York University Statistical based display for positron emission tomography scans
US5687208A (en) * 1995-10-06 1997-11-11 Bhb General Partnership Method of and apparatus for predicting computed tomography contrast enhancement with feedback

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585941A (en) * 1983-02-28 1986-04-29 E. R. Squibb & Sons, Inc. Dosimetry system for strontium-rubidium infusion pump
JPH0627832B2 (ja) * 1990-09-28 1994-04-13 株式会社島津製作所 動態検査自動開始システム
US5924987A (en) * 1997-10-06 1999-07-20 Meaney; James F. M. Method and apparatus for magnetic resonance arteriography using contrast agents

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150292A (en) * 1977-02-18 1979-04-17 Ter Pogossian Michel M Imaging device for computerized emission tomography
US4409966A (en) * 1981-05-29 1983-10-18 Lambrecht Richard M Method and apparatus for injecting a substance into the bloodstream of a subject
US5027817A (en) * 1989-06-22 1991-07-02 New York University Statistical based display for positron emission tomography scans
US5687208A (en) * 1995-10-06 1997-11-11 Bhb General Partnership Method of and apparatus for predicting computed tomography contrast enhancement with feedback

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO0159477A1 *
VOTAW J R: "SIGNAL-TO-NOISE RATIO IN NEURO ACTIVATION PET STUDIES" IEEE TRANSACTIONS ON MEDICAL IMAGING, IEEE INC. NEW YORK, US, vol. 15, no. 2, 1 April 1996 (1996-04-01), pages 197-205, XP000584347 ISSN: 0278-0062 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007054843A1 (fr) * 2005-11-10 2007-05-18 Koninklijke Philips Electronics, N.V. Imagerie par tomographie à émission de positrons avec masque de mode de liste anatomique
GB2450073A (en) * 2006-08-25 2008-12-17 Siemens Molecular Imaging Ltd Regional reconstructions of spatially distributed functions
GB2450073B (en) * 2006-08-25 2009-11-04 Siemens Molecular Imaging Ltd Regional reconstruction of spatially distributed functions
US8150112B2 (en) 2006-08-25 2012-04-03 Siemens Medical Solutions Usa, Inc. Regional reconstruction of spatially distributed functions
CN103279964A (zh) * 2013-04-23 2013-09-04 浙江大学 一种基于prca的pet图像动态重建方法及系统
CN103279964B (zh) * 2013-04-23 2015-10-28 浙江大学 一种基于prca的pet图像动态重建方法及系统
DE102014219196A1 (de) * 2014-09-23 2016-01-14 Siemens Aktiengesellschaft Verfahren und Vorrichtung zur Gewinnung zweier Bilder mittels zweier unterschiedlicher medizinischer Bildgebungsverfahren

Also Published As

Publication number Publication date
WO2001059477A1 (fr) 2001-08-16
AU2001228845A1 (en) 2001-08-20
US20030014132A1 (en) 2003-01-16
JP4408162B2 (ja) 2010-02-03
DE60115848D1 (de) 2006-01-19
US7191109B2 (en) 2007-03-13
JP2001221861A (ja) 2001-08-17
DE60115848T2 (de) 2006-06-14
EP1256817A4 (fr) 2003-05-21
EP1256817B1 (fr) 2005-12-14

Similar Documents

Publication Publication Date Title
EP1256817B1 (fr) Tomographe a emission de positrons
CN102472824B (zh) 具有同位素污染物补偿的动态pet成像装置及方法
JP2004530915A (ja) 核医学撮像における二重アイソトープ検査
US4682604A (en) Coincidence counting emission tomographic probe: method and apparatus
US8249319B2 (en) Nuclear medicine diagnosis apparatus and diagnostic system used thereto
Huang et al. Model dependency and estimation reliability in measurement of cerebral oxygen utilization rate with oxygen-15 and dynamic positron emission tomography
US8527034B2 (en) Image derived input function for PET lung assessment
JP4656008B2 (ja) 核医学診断装置
Budinger Instrumentation trends in nuclear medicine
US20090285749A1 (en) Apparatus and Method for Functional Neurological Screening
CN104024885B (zh) 核医学诊断装置及医用数据处理装置
US8450697B2 (en) Discrimination parameter calculation method for photon detectors, and nuclear medicine diagnostic apparatus using same
US7132663B2 (en) Methods and apparatus for real-time error correction
JPH11153669A (ja) 核医学診断装置
JPH0815439A (ja) 血流量測定装置
JPH1176180A (ja) 血流量測定装置
Budinger Critical review of PET, SPECT and neuroreceptor studies in schizophrenia
JPH05100031A (ja) エミツシヨンｃｔ装置
US20230301605A1 (en) Diagnostic apparatus for nuclear medicine and estimation method of attenuation coefficient image
CN115005850A (zh) 一种放射性活度分布监测系统和方法
Jackson Developments in radionuclide imaging
JPH0634760A (ja) 放射線計測装置及び核医学診断装置
Kanno Pet Instrumentation for Quantitative Tracing of Radiopharmaceuticals
JP2021085782A (ja) 核医学診断装置および核医学データの補正方法
CN109738931A (zh) 一种肾小球滤过率检测设备

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020906

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7G 01T 1/29 B

Ipc: 7G 01T 1/164 A

A4 Supplementary search report drawn up and despatched

Effective date: 20030403

RBV Designated contracting states (corrected)

Designated state(s): AT BE DE SE

17Q First examination report despatched

Effective date: 20040930

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RBV Designated contracting states (corrected)

Designated state(s): DE SE

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE SE

REF Corresponds to:

Ref document number: 60115848

Country of ref document: DE

Date of ref document: 20060119

Kind code of ref document: P

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20060915

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20170125

Year of fee payment: 17

Ref country code: SE

Payment date: 20170111

Year of fee payment: 17

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60115848

Country of ref document: DE

REG Reference to a national code

Ref country code: SE

Ref legal event code: EUG

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180801

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180130